Stride.Start

If you've searched "GLP-1 cost India" and gotten back wildly different numbers — ₹8,000 from one source, ₹25,000 from another — you're not wrong, and they're not lying. The number depends on which drug, which dose, which pharmacy, which city, and what else you're paying for around it. This is the honest breakdown.

The headline drug prices (current, May 2026)

These are approximate monthly pharmacy costs for the most common GLP-1 medications in India.

Drug Dose Monthly cost (₹)
Ozempic (semaglutide) 0.25 mg / 0.5 mg ₹9,000 – ₹13,000
Ozempic 1 mg ₹12,000 – ₹16,000
Ozempic 2 mg ₹15,000 – ₹18,000
Wegovy (semaglutide 2.4 mg) — post Nov 2025 price cut 1.7 mg / 2.4 mg ₹14,200 – ₹16,400
Generic semaglutide (Indian, post Mar 2026 patent expiry) equivalent doses ₹3,000 – ₹6,000
Mounjaro (tirzepatide) — vials 2.5 mg / 5 mg ₹14,000 – ₹17,500
Mounjaro KwikPen 5 mg ₹15,000 – ₹17,500
Mounjaro KwikPen 10 mg ₹20,000 – ₹23,500
Mounjaro KwikPen 15 mg ₹26,000 – ₹27,500
Yurpeak (Cipla tirzepatide) similar to Mounjaro similar
Rybelsus (oral semaglutide) 14 mg / day ₹9,000 – ₹13,000

Two big things shifted in the last 6 months:

  1. Wegovy price cut 37% by Novo Nordisk in November 2025 (originally ₹17,000 – ₹26,000 at June 2025 launch).
  2. Semaglutide Indian patent expired March 20, 2026 — generic versions from Cipla, Sun Pharma, Dr Reddy's, Lupin, Biocon and others are now available at fractions of branded pricing.

These prices shift quickly with supply, parallel imports, and pharma launch pricing. They're directional — always confirm with your treating clinician.

Why the same drug costs different amounts

Five factors:

  1. Pharmacy type — hospital pharmacies are usually more expensive than chain chemists; chain chemists are usually more expensive than authorized e-pharmacies running launch promotions.
  2. City — metros (Mumbai, Delhi, Bangalore) tend to have more competitive pricing than tier-2 cities, where access is harder.
  3. Dose tier — you don't start at maintenance dose. The first 16 weeks cost less because you're on lower doses.
  4. Single pen vs multi-pen pack — buying a 4-week pack is usually cheaper per dose than week-by-week.
  5. Manufacturer's patient programs — Novo Nordisk and Eli Lilly run periodic patient-assistance programs in India; eligibility varies.

The hidden costs nobody mentions

The drug price isn't the full cost. To do this safely and legally, you also need:

Item Cost (₹) Frequency
Initial doctor consultation ₹1,500 – ₹3,500 Once
Comprehensive blood work (CBC, HbA1c, fasting glucose, lipid panel, TSH, kidney + liver) ₹2,500 – ₹5,000 Once at start, repeat at 3 – 6 mo
Follow-up consultations ₹1,000 – ₹2,500 each Every 4 – 6 weeks
Nutrition counselling (separate) ₹1,500 – ₹3,000 / session Variable
Sharps / disposal box ₹500 – ₹1,000 One-off

For a 3-month course, expect to add ₹6,000 – ₹15,000 in non-drug costs on top of the medication price.

A realistic 3-month budget (piecemeal)

Line Low High
Ozempic 1 mg ×3 months ₹36,000 ₹48,000
Initial consultation ₹1,500 ₹3,500
Blood work ₹2,500 ₹5,000
Follow-up consultations (×2) ₹2,000 ₹5,000
Nutrition support ₹0 ₹6,000
3-month piecemeal total ₹42,000 ₹67,500

That's the cost of organising every component yourself — and assuming you correctly chose Ozempic at the right dose, found a licensed pharmacy with cold chain, didn't skip lab work, and showed up to follow-ups.

Stride's pricing, for comparison

3-Month Early Edition: ₹9,999 (regular ₹23,999).

Includes:

  • Online assessment (gender, weight, height, history, conditions, goals)
  • At-home blood test, scheduled at 8 AM on a date you choose
  • Doctor video consultation
  • GLP-1 medication delivery monthly, when clinically appropriate
  • Personalized nutrition support
  • Ongoing care-team check-ins for the full 3 months

One-time payment. No subscription auto-renewal.

The bundled price is structured this way because we deliver the program at scale — your individual lab partner, pharmacy logistics, doctor time, and follow-up cycle are part of a single supervised flow rather than a series of disconnected purchases.

Insurance and tax

Insurance — Most Indian retail health insurance policies do not cover obesity medications. Some corporate group policies and premium individual policies cover GLP-1s when prescribed for type 2 diabetes, but rarely for weight management alone. Check your specific policy's exclusions list — search for "obesity," "lifestyle disease," or "weight management."

Tax (Section 80D) — Medical consultations and prescribed medications for treatment of a covered condition are generally eligible for deduction under Section 80D, subject to overall limits. Talk to your CA — this is general guidance, not tax advice.

How to actually save money

  1. Get the right drug the first time. A doctor-led assessment costs much less than a wrong dose for 3 months.
  2. Bundle. Programs like Stride's Early Edition are priced for the full program, not per-item.
  3. Don't skip labs. Skipping lab work to save ₹3,000 doesn't save money — it raises risk and often leads to suboptimal dosing.
  4. Don't buy from "discount" online sources. Counterfeit or cold-chain-failed GLP-1 is the most expensive thing you can buy.
  5. Plan for a full program, not a month. Stopping and restarting is more expensive than staying on a continuous plan.

Frequently asked questions

What's the cheapest GLP-1 in India in 2026? Rybelsus (oral semaglutide) at ~₹9,000 – ₹13,000 / month at the highest dose. It produces less weight loss than injections but is shelf-stable and an option for patients who won't or can't inject.

Is Wegovy more expensive than Ozempic? Not anymore. After Novo Nordisk's November 2025 price cut, branded Wegovy 2.4 mg is in the ₹15,500 – ₹16,400 / month range — comparable to or below Ozempic 2 mg (₹15,000 – ₹18,000). Generic semaglutide (post March 2026) is significantly cheaper than both.

Does insurance cover GLP-1 in India? Most retail policies don't. Some corporate and premium policies cover them for type 2 diabetes. Coverage for weight-management-only indication is rare in 2026.

Are generic versions of semaglutide available in India? Yes — as of March 20, 2026 (when the Indian patent expired), at least 5 Indian manufacturers (Cipla, Sun Pharma, Dr Reddy's, Lupin, Biocon) have launched generic semaglutide at ₹3,000 – ₹6,000 per month. Branded Wegovy and Ozempic remain available alongside. Tirzepatide (Mounjaro) is still patent-protected — no legal generics.

Can I import GLP-1 from abroad to save money? Personal-import of prescription injections is heavily restricted in India. Cold-chain failure during transit is common. This is not a safe or cost-effective path.

What does Stride's ₹9,999 actually include? Assessment, at-home blood test, doctor video consultation, monthly GLP-1 medication delivery (when clinically appropriate), nutrition support, and 3 months of care-team check-ins. One-time payment, no auto-renewal.

Ready to start?

Check your eligibility — the assessment takes 60 seconds.

Prescription medication delivery
Prescription medication delivery
Telemedicine consultation — bundled care saves money vs piecemeal
Telemedicine consultation — bundled care saves money vs piecemeal
Ready when you are

Doctor-led, continuously monitored.

3-Month Early Edition: ₹9,999 (regular ₹23,999). One-time payment, no auto-renewal.

Check Your Eligibility